WINTON GROUP Ltd Makes New $164,000 Investment in InfuSystem Holdings, Inc. (NYSE:INFU)

WINTON GROUP Ltd bought a new position in shares of InfuSystem Holdings, Inc. (NYSE:INFU) during the fourth quarter, HoldingsChannel reports. The fund bought 19,410 shares of the company’s stock, valued at approximately $164,000.

Other institutional investors have also modified their holdings of the company. BNP Paribas Financial Markets lifted its position in InfuSystem by 66.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company’s stock worth $27,000 after acquiring an additional 1,626 shares during the period. Legato Capital Management LLC purchased a new stake in shares of InfuSystem during the fourth quarter worth approximately $85,000. Summit Global Investments purchased a new stake in shares of InfuSystem during the fourth quarter worth approximately $86,000. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of InfuSystem during the third quarter worth $87,000. Finally, Sei Investments Co. purchased a new position in InfuSystem in the 4th quarter valued at $90,000. 71.13% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently commented on INFU. StockNews.com upgraded shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 14th. Sidoti upgraded shares of InfuSystem to a “strong-buy” rating in a research report on Tuesday, March 18th.

InfuSystem Trading Down 1.6 %

Shares of INFU stock opened at $5.38 on Tuesday. InfuSystem Holdings, Inc. has a 1-year low of $5.26 and a 1-year high of $9.97. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The business’s fifty day moving average price is $7.18 and its 200 day moving average price is $7.53. The firm has a market capitalization of $113.03 million, a PE ratio of 89.68 and a beta of 1.75.

InfuSystem Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.